Representative photomicrographs of DAB immunohistochemistry for the marker of the medium spiny neurons, calbindin-28K (CALB, black), in the striatum of a (A) wild-type mouse, (B) vehicle treated R6/2 mouse, and (C) R6/2 mouse treated with TP10 from 4 to 13 weeks of age. There is a marked decrease in neuronal count in the sample from a vehicle treated R6/2 mice compared to wild-type mice and TP10 treated R6/2 mice. (D) Quantification of the number of striatal neurons labeled with CALB. Striatal neuron counts were carried out (see Methods) on sections from wild type and vehicle- or TP-10-treated R6/2 mice (n = 6/group). An ANOVA indicated an overall significant effect of group (F(2,90) = 36,48; p<0.0000). Post hoc analysis indicated that R6/2 mice treated with vehicle had a significantly reduced density of CALB-positive neurons in striatum compared to the wild type group. The density of striatal neurons in R6/2 mice treated with TP-10 was not statistically different to that of wild type mice, and was significantly greater than that of the vehicle treated R6/2 animals (p<0.0001). (E) Area of striatal neuron cell bodies labeled with CALB. Cell body area of approximately 400 neurons per animal (n = 6/group) was measured using Zeiss LSM software. An ANOVA indicated an overall significant effect of group (F(2,899) = 61,64; p<0.0000). Post hoc analysis indicated that R6/2 mice treated with vehicle had a significantly reduction in the size of striatal neurons compared to wild type animals (p<0.00002). The size of striatal neurons in R6/2 animals treated with TP-10 was not statistically different to that in wild type animals, and was significantly greater than that of the vehicle treated R6/2 animals (p<0.00002).